New research is being presented at ASCO 2013, the annual meeting of the American Society of Clinical Oncology, from May 31-June 4 in Chicago. Find everything here that you need to know before and during the conference.
Watch Scientific Program Committee Chair Dr. Douglas Yee discuss how the 2013 ASCO Annual Meeting reflects the priorities and issues that affect every oncology professional:
Meeting Highlights
Cancer Care Costs: A Look at Patient Expectations
Involving Family in Cancer Treatment Decisions
Deciding on When to Operate in Lung Cancer
Family Physicians’ Care of Cancer Patients
News from the Meeting
Men’s Fitness in Middle Age Protects Against Cancer
Surveillance Imaging Ineffective in Detecting Lymphoma Relapse
Post-Surgery Surveillance Sufficient for Men with Stage I Seminoma
Anti-PD-L1 Drug Shows Promising Anti-Cancer Effects
Standard-Dose Radiation Best for Stage III NSCLC
Funding Cuts Threaten Modernization of Cancer Research
Is Nivolumab a ‘Breakthrough’ in Melanoma?
Growth Factor Improves Ipilimumab Efficacy in Melanoma
Pazopanib Improves PFS in Advanced Ovarian Cancer
Breakthrough in Rare Eye Cancer: First Drug That Works
Cetuximab Superior to Bevacizumab as First-Line Tx in CRC
Tamoxifen for 10 Years Has Benefits, Says aTTom
Bevacizumab Prolongs Survival in Advanced Cervical Cancer
Sorafenib Potent New Tx for Advanced Thyroid Cancer
Drug Combos Are the Future of Melanoma Treatment
Cancer Drug Shortages Spawn Workarounds
Cervical Cancer Screening With Vinegar Reduces Mortality
No Benefit to Bevacizumab for Newly Diagnosed Glioblastoma?
Novel Agent Shows Potential for Advanced Lung Cancer
Strong Case for Weekly Paclitaxel in Breast Cancer
Stop Using Calcium and Magnesium With Oxaliplatin
Targeted Duo Boosts OS in Melanoma
Herpes-Derived Tx for Melanoma?
Dual Immune Tx Tag Teams Melanoma
Sorafenib Halts Resistant Thyroid Cancer
Targeted Drug Tops Chemo for Lung Cancer
HPV-Oral Cancer Won’t Threaten Spouses
Screen for Clot Risk at Start of Chemo
GALAXY-1 ‘Proof of Principle’ in Lung Ca Tx
Actor’s Oral Sex Remarks May Aid HPV Prevention
Are CT Scans Needed for Lymphoma?
Targeted Agent Has Slim NSCLC Benefit
Agent May Be NSCLC ‘Game Changer’
Weekly Chemo Better in Ovarian Cancer
More from the Meeting
